This finding is consistent with the increased carriage of erm(B) in streptococci reported in healthy individuals following 180 days of treatment with azithromycin or clarithromycin (39) and with culture-based assessments of resistance carriage following long-term macrolide use in bronchiectasis patients (40). Here, ETV5 is linked to bronchiectasis.